Wire Stories
810Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical...
- 806
MOGU Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
Live Video Broadcast Business (“LVB”) Maintains Robust Growth Momentum with GMV in the Fourth Quarter and Fiscal Year 2020 Increasing 54.1% and...
- 819
Indian OTT and Pay TV Market Analysis and Trajectory 2018-2025 – Netflix, Amazon Prime Video, Disney+, Apple TV+, Zee5 and More – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India OTT and Pay TV Forecasts” report has been added to ResearchAndMarkets.com’s offering. This 36-page PDF report covers the converging...
- 747
Renesas Electronics Announces Consolidated Forecasts for the Second Quarter and First Half of 2020
TOKYO–(BUSINESS WIRE)–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts for the three...
- 880
Wipro Appoints Thierry Delaporte as CEO & Managing Director
EAST BRUNSWICK, N.J. & BANGALORE, India–(BUSINESS WIRE)–#RishadPremji–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business...
- 1.0K
Wipro Limited Appoints Deepak M Satwalekar to its Board
BANGALORE, India & EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–#DeepakSatwalekar–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting, and business...
- 777
Reveal Group is First and Only Partner to Achieve Blue Prism “Double Platinum” Capability Certification
Company Sets New Standard for Intelligent Automation Delivery Capabilities NEW YORK & SYDNEY–(BUSINESS WIRE)–#BluePrism—Reveal Group, a global leader in Robotic Process Automation...
- 793
New data show first-line triplet regimen of pembrolizumab, Herzuma® (biosimilar trastuzumab) and chemotherapy are effective in treatment of HER2-positive advanced gastric cancer
Data from a phase Ib/II trial show a first-line triple combination therapy of pembrolizumab, Herzuma®(biosimilar trastuzumab) and chemotherapy was effective in patients...
- 760
European Commission Releases Takeda From Commitment to Divest Shire’s Pipeline Compound SHP647
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announces that on May 28, the European Commission (the “EC”) has released...
- 749
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19
PETALUMA, Calif.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide...
